產品描述: WZ4003 is the first potent and highly specific NUAK kinase inhibitor with IC50 of 20 nM/100 nM for NUAK1 (ARK5)/NUAK2, without significant inhibition on other 139 kinases. |
靶點:
NUAK1:20 nM (IC50);NUAK2:100 nM (IC50);AMPK |
參考文獻:
1. Banerjee S, et al. Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases. Biochem J. 2014 Jan 1;457(1):215-25. 2. Zhou W, et al. Novel mutant-selective EGFR kinase inhibitors against EGFR T790M. Nature. 2009 Dec 24;462(7276):1070-4 |
溶解性:
DMSO : 33.33 mg/mL (67.06 mM; Need ultrasonic) |
保存條件:
-20℃ |
配置溶液濃度參考:
|
1mg |
5mg |
10mg |
1 mM |
2.012 ml |
10.061 ml |
20.121 ml |
5 mM |
0.402 ml |
2.012 ml |
4.024 ml |
10 mM |
0.201 ml |
1.006 ml |
2.012 ml |
50 mM |
0.04 ml |
0.201 ml |
0.402 ml |
|
注意: |
部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |